Interleukin Genetics Retains Top Life Science Communicat...(nd uncertainties actual results may diff...)

Date:3/18/2008

nd uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward- looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence, delays in product development, the performance of our commercial partners, the availability of adequate capital, the actions of our competitors and other competitive risks, and those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2006 as amended, filed with the Securities and Exchange Commission, our quarterly reports on Form 10- Q and other filings made by us with the Securities and Exchange Commission. We disclaim any obligation or intention to update these forward-looking statements.

'/>"/>

SOURCE Interleukin Genetics, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
2. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
5. Interleukin Genetics Announces Management and Board Appointments
6. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. deCODE Genetics Announces Full-year 2007 Financial Results
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
10. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
11. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service